Market Currents
Covidien (COV +2.2%) trades higher after announcing the FDA has issued a clearance for the...
-
Thursday, December 1, 2011, 1:55 PM ETCovidien (COV +2.2%) trades higher after announcing the FDA has issued a clearance for the company's SpiderFX, an embolic protection device for the treatment of severely calcified arterial lesions in the lower extremities.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
